Molecular profiling and relationship with clinical response in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class potent inhibitor of mutant IDH1, in addition to data from the completed dose escalation portion of the phase 1 study Meeting Abstract
| Authors: | DiNardo, C.; de Botton, S.; Pollyea, D. A.; Stein, E. M.; Fathi, A. T.; Roboz, G. J.; Collins, R.; Swords, R. T.; Flinn, I. W.; Altman, J. K.; Tallman, M. S.; Kantarjian, H. M.; Derti, A.; Goldwasser, M.; Prahl, M.; Wu, B.; Yen, K.; Agresta, S.; Stone, R. M. |
| Abstract Title: | Molecular profiling and relationship with clinical response in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class potent inhibitor of mutant IDH1, in addition to data from the completed dose escalation portion of the phase 1 study |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019004106 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.1306.1306 |
| Notes: | Meeting Abstract: 1306 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
Altmetric
Citation Impact
Related MSK Work